Kennedy And Obama Bills Target Home Brews, Genetic Tests
This article was originally published in The Gray Sheet
Executive Summary
Two bipartisan bills introduced last month in the U.S. Senate attempt to address concerns that laboratories are employing new diagnostic tests without sufficient government oversight
You may also be interested in...
BIO Plans Lobbying Push To Improve Payments For Diagnostics
The Biotechnology Industry Organization is adding its lobbying muscle to diagnostic industry efforts to improve payment policies for molecular tests, hoping for a warm reception from lawmakers who are already focused on personalized medicine issues.
BIO Plans Lobbying Push To Improve Payments For Diagnostics
The Biotechnology Industry Organization is adding its lobbying muscle to diagnostic industry efforts to improve payment policies for molecular tests, hoping for a warm reception from lawmakers who are already focused on personalized medicine issues.
Would Expanded Lab-Test Regulation Overstep FDA’s Legal Limits?
Efforts to alter the way laboratory tests are regulated highlight the need to better define FDA's authority over certain medical products